Quick Answer
Insight Molecular Diagnostics Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $4.06 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +115.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Insight Molecular Diagnostics Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 233.5%.
- Historical annual values: Fiscal year 2025: $4.06 million | Fiscal year 2024: $1.88 million | Fiscal year 2023: $1.50 million | Fiscal year 2022: $958.0 thousand | Fiscal year 2021: $2.20 million | Fiscal year 2020: $1.22 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: